Evaluation of benazepril in cats with heart disease in a prospective, randomized, blinded, placebo‐controlled clinical trial by King, Jonathan N., Martin, Mike, Chetboul, Valérie, Ferasin, Luca, French, Anne T., Strehlau, Günther, Seewald, Wolfgang, Smith, Sarah G. W., Swift, Simon T., Roberts, Susan L., Harvey, Andrea M., Little, Christopher J. L., Caney, Sarah M. A., Simpson, Kerry E., Sparkes, Andrew H., Mardell, Eleanor J., Bomassi, Eric, Muller, Claude, Sauvage, John P., Diquélou, Armelle, Schneider, Matthias A., Brown, Laurence J., Clarke, David D., Rousselot, Jean‐Francois

Get full text

Comparison of hydroalcoholic rubbing and conventional chlorhexidine scrubbing for aseptic skin preparation in dogs by Asimus, Erik, Palierne, Sophie, Blondel, Margaux, Pollet, Valentine, Ferran, Aude, Bousquet‐Melou, Alain, Rousselot, Jean‐François, Autefage, André

Get full text

Moving from information and collaboration to action: report from the 3rd International Dog Health Workshop, Paris in April 2017 by O'Neill, Dan G, Keijser, Sylvia F A, Hedhammar, Åke, Kisko, Caroline, Leroy, Gregoire, Llewellyn-Zaidi, Aimée, Malm, Sofia, Olson, Patricia N, Packer, Rowena M A, Rousselot, Jean Francois, Seath, Ian J, Stull, Jason W, Bonnett, Brenda N

Get full text

Long-term tolerability of benazepril in dogs with congestive heart failure by Pouchelon, Jean-Louis, King, Jonathan, Martignoni, Laure, Chetboul, Valérie, Lugardon, Béatrice, Rousselot, Jean-François, Corlouer, Jean-Philippe, Bussadori, Claudio, Piette, Marie-Hélène, Brownlie, Serena, Martel, Philippe, Garcin, Jean-Pierre, Hagen, Andreas, Amberger, Christophe, Martin, Michael, Labadie, Fabrice, Collet, Michel, Drouard, Christine, Lombard, Christophe, Hervé, Daniel, Strehlau, Günther

Get full text

Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study by Rea, Delphine, Nicolini, Franck E., Tulliez, Michel, Guilhot, François, Guilhot, Joelle, Guerci-Bresler, Agnès, Gardembas, Martine, Coiteux, Valérie, Guillerm, Gaelle, Legros, Laurence, Etienne, Gabriel, Pignon, Jean-Michel, Villemagne, Bruno, Escoffre-Barbe, Martine, Ianotto, Jean-Christophe, Charbonnier, Aude, Johnson-Ansah, Hyacinthe, Noel, Marie-Pierre, Rousselot, Philippe, Mahon, François-Xavier

Get full text

Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study by Rea, Delphine, Henry, Guylaine, Khaznadar, Zena, Etienne, Gabriel, Guilhot, François, Nicolini, Franck, Guilhot, Joelle, Rousselot, Philippe, Huguet, Françoise, Legros, Laurence, Gardembas, Martine, Dubruille, Viviane, Guerci-Bresler, Agnès, Charbonnier, Aude, Maloisel, Frédéric, Ianotto, Jean-Christophe, Villemagne, Bruno, Mahon, François-Xavier, Moins-Teisserenc, Hélène, Dulphy, Nicolas, Toubert, Antoine

Get full text

Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia by Chalandon, Yves, Thomas, Xavier, Hayette, Sandrine, Cayuela, Jean-Michel, Abbal, Claire, Huguet, Françoise, Raffoux, Emmanuel, Leguay, Thibaut, Rousselot, Philippe, Lepretre, Stéphane, Escoffre-Barbe, Martine, Maury, Sébastien, Berthon, Céline, Tavernier, Emmanuelle, Lambert, Jean-François, Lafage-Pochitaloff, Marina, Lhéritier, Véronique, Chevret, Sylvie, Ifrah, Norbert, Dombret, Hervé

Get full text

Second tyrosine kinase inhibitor discontinuation attempt in patients with chronic myeloid leukemia by Legros, Laurence, Nicolini, Franck E., Etienne, Gabriel, Rousselot, Philippe, Rea, Delphine, Giraudier, Stéphane, Guerci‐Bresler, Agnès, Huguet, Françoise, Gardembas, Martine, Escoffre, Martine, Ianotto, Jean‐Christophe, Noël, Marie‐Pierre, Varet, Bruno R., Pagliardini, Thomas, Touitou, Irit, Morisset, Stéphane, Mahon, Francois‐Xavier

Get full text

Dasatinib plus Peg‐Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA‐PegIFN study) by Roy, Lydia, Chomel, Jean‐Claude, Guilhot, Joëlle, Guerci‐Bresler, Agnès, Escoffre‐Barbe, Martine, Giraudier, Stéphane, Charbonnier, Aude, Dubruille, Viviane, Huguet, Françoise, Johnson‐Ansah, Hyacinthe, Lenain, Pascal, Ame, Shanti, Etienne, Gabriel, Nicolini, Franck E., Rea, Delphine, Cony‐Makhoul, Pascale, Courby, Stéphane, Ianotto, Jean‐Christophe, Legros, Laurence, Machet, Antoine, Coiteux, Valérie, Hermet, Eric, Cayssials, Emilie, Bouchet, Stéphane, Mahon, Francois‐Xavier, Rousselot, Philippe, Guilhot, François

Get full text

Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study by Rousselot, Philippe, Prost, Stéphane, Guilhot, Joelle, Roy, Lydia, Etienne, Gabriel, Legros, Laurence, Charbonnier, Aude, Coiteux, Valérie, Cony‐Makhoul, Pascale, Huguet, Francoise, Cayssials, Emilie, Cayuela, Jean‐Michel, Relouzat, Francis, Delord, Marc, Bruzzoni‐Giovanelli, Heriberto, Morisset, Laure, Mahon, François‐Xavier, Guilhot, François, Leboulch, Philippe

Get full text

Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: Recommendations for clinical practice from the French Chronic Myeloid Leukemia Study Group by Rea, Delphine, Ame, Shanti, Berger, Marc, Cayuela, Jean‐Michel, Charbonnier, Aude, Coiteux, Valérie, Cony‐Makhoul, Pascale, Dubruille, Viviane, Dulucq, Stéphanie, Etienne, Gabriel, Legros, Laurence, Nicolini, Franck, Roche‐Lestienne, Catherine, Escoffre‐Barbe, Martine, Gardembas, Martine, Guerci‐Bresler, Agnès, Johnson‐Ansah, Hyacinthe, Rigal‐Huguet, Françoise, Rousselot, Philippe, Mahon, François‐Xavier

Get full text

Burden of liver disease progression in hospitalized patients with type 2 diabetes mellitus by Mallet, Vincent, Parlati, Lucia, Martinino, Alessandro, Scarano Pereira, Juan Pablo, Jimenez, Carmen Navas, Sakka, Mehdi, Bouam, Samir, Retbi, Aurelia, Krasteva, Donika, Meritet, Jean-François, Schwarzinger, Michaël, Thabut, Dominique, Rufat, Pierre, Bonnefont-Rousselot, Dominique, Sogni, Philippe, Pol, Stanislas, Tsochatzis, Emmanuel, Fontaine, Hélène, Corouge, Marion, Pichard, Anaïs Vallet, Hollande, Clémence, Terris, Benoit, Larger, Etienne, Bertherat, Jérome, Ratziu, Vlad, Hartemann, Agnès

Get full text

Constitutional DNA Polymorphisms Associated with the Plasma Imatinib Concentration in Chronic Myeloid Leukemia Patients by Bruzzoni-Giovanelli, Heriberto, Zouali, Habib, Sahbatou, Mourad, Maneglier, Benjamin, Cayuela, Jean-Michel, Rebollo, Angelita, Marin, Gustavo H, Geromin, Daniela, Tomczak, Carole, Alberdi, Antonio, Deleuze, Jean-Francois, Rousselot, Philippe

Get full text

Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL by Passet, Marie, Kim, Rathana, Gachet, Stéphanie, Sigaux, François, Chaumeil, Julie, Galland, Ava, Sexton, Thomas, Quentin, Samuel, Hernandez, Lucie, Larcher, Lise, Bergugnat, Hugo, Ye, Tao, Karasu, Nezih, Caye, Aurélie, Heizmann, Beate, Duluc, Isabelle, Chevallier, Patrice, Rousselot, Philippe, Huguet, Françoise, Leguay, Thibaut, Hunault, Mathilde, Pflumio, Françoise, Freund, Jean-Noël, Lobry, Camille, Lhéritier, Véronique, Dombret, Hervé, Domon-Dell, Claire, Soulier, Jean, Boissel, Nicolas, Clappier, Emmanuelle

Get full text

Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients by Rousselot, Philippe, Mollica, Luigina, Guilhot, Joëlle, Guerci, Agnès, Nicolini, Franck E., Etienne, Gabriel, Legros, Laurence, Charbonnier, Aude, Coiteux, Valérie, Dartigeas, Caroline, Escoffre‐Barbe, Martine, Roy, Lydia, Cony-Makhoul, Pascale, Dubruille, Viviane, Gardembas, Martine, Huguet, Françoise, Réa, Delphine, Cayssials, Emilie, Guilhot, François, Bergeron, Anne, Molimard, Mathieu, Mahon, Francois-Xavier, Cayuela, Jean-Michel, Busque, Lambert, Bouchet, Stéphane

Get full text

Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML Patients by Nicolini, Franck Emmanuel, Dulucq, Stéphanie, Boureau, Lisa, Cony-Makhoul, Pascale, Charbonnier, Aude, Escoffre-Barbe, Martine, Rigal-Huguet, Françoise, Coiteux, Valérie, Varet, Bruno, Dubruille, Viviane, Lenain, Pascal, Rousselot, Philippe, Rea, Delphine, Guerci-Bresler, Agnès, Legros, Laurence, Liu, Jixing, Gardembas, Martine, Ianotto, Jean-Christophe, Turlure, Pascal, Johnson-Ansah, Hyacinthe, Martiniuc, Juliana, Jardel, Henry, Joly, Bertrand, Zunic, Patricia, Henni, Tawfiq, Villemagne, Bruno, Berger, Marc G, Cayssials, Emilie, Guilhot, François, Larosa, Fabrice, Guilhot, Joëlle, Etienne, Gabriel, Mahon, François-Xavier

Get full text

CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas by Appay, Romain, Dehais, Caroline, Maurage, Claude-Alain, Alentorn, Agusti, Carpentier, Catherine, Colin, Carole, Ducray, François, Escande, Fabienne, Idbaih, Ahmed, Kamoun, Aurélie, Marie, Yannick, Mokhtari, Karima, Tabouret, Emeline, Trabelsi, Nesrine, Uro-Coste, Emmanuelle, Delattre, Jean-Yves, Figarella-Branger, Dominique

Get full text

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts by Abboud, Camille, Berman, Ellin, Cohen, Adam, Cortes, Jorge, DeAngelo, Daniel, Deininger, Michael, Devine, Steven, Druker, Brian, Fathi, Amir, Jabbour, Elias, Jagasia, Madan, Kantarjian, Hagop, Khoury, Jean, Laneuville, Pierre, Larson, Richard, Lipton, Jeffrey, Moore, Joseph O., Mughal, Tariq, O’Brien, Susan, Pinilla-Ibarz, Javier, Quintas-Cardama, Alfonso, Radich, Jerald, Reddy, Vishnu, Schiffer, Charles, Shah, Neil, Shami, Paul, Silver, Richard T., Snyder, David, Stone, Richard, Talpaz, Moshe, Tefferi, Ayalew, Van Etten, Richard A., Wetzler, Meir, Abruzzese, Elisabetta, Apperley, Jane, Breccia, Massimo, Byrne, Jenny, Cervantes, Francisco, Chelysheva, Ekaterina, Clark, R. E., de Lavallade, Hugues, Dyagil, Iryna, Gambacorti-Passerini, Carlo, Goldman, John, Haznedaroglu, Ibrahim, Hjorth-Hansen, Henrik, Holyoake, Tessa, Huntly, Brian, le Coutre, Philipp, Lomaia, Elza, Mahon, Francois-Xavier, Marin-Costa, David, Martinelli, Giovanni, Mayer, Jiri, Milojkovic, Dragana, Olavarria, Eduardo, Porkka, Kimmo, Richter, Johan, Rousselot, Philippe, Saglio, Giuseppe, Saydam, Guray, Stentoft, Jesper, Turkina, Anna, Vigneri, Paolo, Zaritskey, Andrey, Aguayo, Alvaro, Ayala, Manuel, Bendit, Israel, Maria Bengio, Raquel, Best, Carlos, Bullorsky, Eduardo, Cervera, Eduardo, DeSouza, Carmino, Fanilla, Ernesto, Gomez-Almaguer, David, Hamerschlak, Nelson, Lopez, Jose, Magarinos, Alicia, Meillon, Luis, Milone, Jorge, Moiraghi, Beatriz, Pasquini, Ricardo, Pavlovsky, Carolina, Ruiz-Arguelles, Guillermo J., Spector, Nelson, Arthur, Christopher, Browett, Peter, Grigg, Andrew, Hu, Jianda, Huang, Xiao-jun, Hughes, Tim, Jiang, Qian, Jootar, Saengsuree, Kim, Dong-Wook, Malhotra, Hemant, Malhotra, Pankaj, Matsumura, Itaru, Melo, Junia, Ohnishi, Kazunori

Get full text

Long-term outcome of imatinib 400 mg compared to imatinib 600 mg or imatinib 400 mg daily in combination with cytarabine or pegylated interferon alpha 2a for chronic myeloid leukae... by Guilhot, Francois, Rigal-Huguet, Françoise, Guilhot, Joëlle, Guerci-Bresler, Agnès-Paule, Maloisel, Frédéric, Rea, Delphine, Coiteux, Valérie, Gardembas, Martine, Berthou, Christian, Vekhoff, Anne, Jourdan, Eric, Berger, Marc, Fouillard, Loïc, Alexis, Magda, Legros, Laurence, Rousselot, Philippe, Delmer, Alain, Lenain, Pascal, Escoffre Barbe, Martine, Gyan, Emmanuel, Bulabois, Claude-Eric, Dubruille, Viviane, Joly, Bertrand, Pollet, Bertrand, Cony-Makhoul, Pascale, Johnson-Ansah, Hyacinthe, Mercier, Melanie, Caillot, Denis, Charbonnier, Aude, Kiladjian, Jean-Jacques, Chapiro, Jacques, Penot, Amélie, Dorvaux, Véronique, Vaida, Iona, Santagostino, Alberto, Roy, Lydia, Zerazhi, Hacene, Deconinck, Eric, Maisonneuve, Herve, Plantier, Isabelle, Lebon, Delphine, Arkam, Yazid, Cambier, Nathalie, Ghomari, Kamel, Miclea, Jean-Michel, Glaisner, Sylvie, Cayuela, Jean-Michel, Chomel, Jean-Claude, Muller, Marc, Lhermitte, Ludovic, Delord, Marc, Preudhomme, Claude, Etienne, Gabriel, Mahon, François-Xavier, Nicolini, Franck- Emmanuel

Get full text

Prognostication of Molecular Relapses after Dasatinib or Nilotinib Discontinuation in Chronic Myeloid Leukemia (CML): A FI-LMC STOP 2G-TKI Study Update by Rea, Delphine, Nicolini, Franck E, Tulliez, Michel, Rousselot, Philippe, Gardembas, Martine, Etienne, Gabriel, Guilhot, Francois, Guilhot, Joelle, Guerci, Agnès, Escoffre-Barbe, Martine, Legros, Laurence, Villemagne, Bruno, Guillerm, Gaëlle, Noel, Marie-Pierre, Coiteux, Valerie, Pignon, Jean-Michel, Mahon, Francois-Xavier

Get full text